The long-term goal of this project is to expand the range of therapies for bacterial infections that: 1) can effectively treat even antibiotic-resistan organisms; and 2) do not contribute to the further development of antibiotic resistance. This project will explore a new approach using photodynamic therapy for urinary tract infections in people who use catheters for medical purposes. Over a million cases of urinary tract infections are diagnosed each year in this population, and the repeated use of antibiotics to treat these infections is contributing to the spread of drug-resistant organisms. This new approach combines two common and inexpensive drugs (methylene blue, MB and potassium iodide, KI) that will be delivered to the bladder of infected patients and then will be activated by a fiber-opic light source introduced into the bladder. This newly discovered drug combination is synergistic and KI enhances killing by up to 1000-fold compared to the killing using light and MB alone. The light treatment should be applied almost immediately after drug treatment to spare the normal bladder tissue. This approach may enable the eradication of urinary tract infections without the use of antibiotics and without the potential to encourage development of additional treatment resistant in target organisms. Only initial bench studies have been done on the use of photodynamic therapy to treat urinary tract infections. Therefore, the specific aims of this projec are to show that the specific drug combination activated by light can effectively kill a range of bacteria that cause urinary tract infections, including those that are antibiotic-resistant; and tht this photodynamic therapy can be used to eradicate bacterial infections without causing significant damage to the bladder. In the first phase of this project studies will be done with an already-identified drug combination, testing it in bacterial cultures and in small animal models. I the second phase of the project, studies will be done to identify new second generation drug combinations and less expensive LED light sources in order to make treatment more effective and less expensive. Finally, an optimized treatment combination will be tested in a pig model, where the bladder is similar to a human bladder, to show that the photodynamic therapy can eradicate the same kind of bacteria that infect people who have urinary tract infections caused by catheter use.

Public Health Relevance

Over a million cases of urinary tract infections are diagnosed each year in people who use urinary catheters for medical purposes, and the repeated use of antibiotics to treat these infections contributes to the spread of antibiotic-resistant bacteria. Tis project addresses U.S. public health by investigating a different method of killing bacteria and treating bladder infections that does not use antibiotics and does not contribute to the further development of antibiotic resistance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI121700-01
Application #
9021443
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Ernst, Nancy Lewis
Project Start
2015-12-01
Project End
2017-11-30
Budget Start
2015-12-01
Budget End
2016-11-30
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
Heiskanen, Vladimir; Hamblin, Michael R (2018) Photobiomodulation: lasers vs. light emitting diodes? Photochem Photobiol Sci 17:1003-1017
George, Sajan; Hamblin, Michael R; Abrahamse, Heidi (2018) Effect of red light and near infrared laser on the generation of reactive oxygen species in primary dermal fibroblasts. J Photochem Photobiol B 188:60-68
Avci, Pinar; Karimi, Mahdi; Sadasivam, Magesh et al. (2018) In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging. Virulence 9:28-63
Ghasemi, Amir; Rabiee, Navid; Ahmadi, Sepideh et al. (2018) Optical assays based on colloidal inorganic nanoparticles. Analyst 143:3249-3283
Hamblin, Michael R; Nelson, Scott T; Strahan, Justin R (2018) Photobiomodulation and Cancer: What Is the Truth? Photomed Laser Surg 36:241-245
Malekzad, Hedieh; Zangabad, Parham Sahandi; Mohammadi, Hadi et al. (2018) Noble metal nanostructures in optical biosensors: Basics, and their introduction to anti-doping detection. Trends Analyt Chem 100:116-135
Huang, Liyi; El-Hussein, Ahmed; Xuan, Weijun et al. (2018) Potentiation by potassium iodide reveals that the anionic porphyrin TPPS4 is a surprisingly effective photosensitizer for antimicrobial photodynamic inactivation. J Photochem Photobiol B 178:277-286
Huang, Liyi; Wang, Min; Huang, Ying-Ying et al. (2018) Progressive cationic functionalization of chlorin derivatives for antimicrobial photodynamic inactivation and related vancomycin conjugates. Photochem Photobiol Sci 17:638-651
Chan, Agnes S; Lee, Tsz Lok; Yeung, Michael K et al. (2018) Photobiomodulation improves the frontal cognitive function of older adults. Int J Geriatr Psychiatry :
Rineh, Ardeshir; Bremner, John B; Hamblin, Michael R et al. (2018) Attaching NorA efflux pump inhibitors to methylene blue enhances antimicrobial photodynamic inactivation of Escherichia coli and Acinetobacter baumannii in vitro and in vivo. Bioorg Med Chem Lett 28:2736-2740

Showing the most recent 10 out of 95 publications